Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

The Lancet Infectious Diseases

Volumn 17, Issue 5, 2017, Pages 545-552

  Etard, Jean François ^a   Sow, Mamadou Saliou ^b,h   Leroy, Sandrine ^a,c,h   Touré, Abdoulaye ^a,d,h   Taverne, Bernard ^a,h   Keita, Alpha Kabinet ^a,h   Msellati, Philippe ^a,h   Magassouba, N'Fally ^b,h   Baize, Sylvain ^e,h   Raoul, Hervé ^f,h   Izard, Suzanne ^a,h   Kpamou, Cécé ^a,h   March, Laura ^a,h   Savane, Ibrahima ^g   Barry, Moumié ^b,h   Delaporte, Eric ^a,h   Ayouba, Ahidjo ^h   Bangoura, Kaba ^h   Barry, Alimou ^h   Cissé, Mamoudou ^h   Cissé, Mohammed ^h   Delfraissy, Jean François ^h   Delmas, Christelle ^h   Desclaux, Alice ^h   Diallo, Saliou Bella ^h   Diallo, Mamadou Safiatou ^h   Diallo, Mariama Sadjo ^h   Étard, Jean François ^h   Etienne, Cécile ^h   Faye, Ousmane ^h   Fofana, Ibrahima ^h   Granouillac, Bruno ^h   Hébert, Esther Hereth ^h   Kassé, Djenaba ^h   Keita, Sakoba ^h   Koivogui, Lamine ^h   Lacarabaratz, Christine ^h   Marchal, Claire Levy ^h   Levy, Yves ^h   Mendiboure, Vincent ^h   Niane, Harissatou ^h   Peeters, Martine ^h   Pers, Yves Marie ^h   Sacko, Sidi Lamine ^h   Savané, Ibrahima ^h   Traoré, Fodé Amara ^h   Traoré, Falaye ^h   Youla, Yamoussa ^h   Yazdanpanah, Yazdan ^h   more..

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b Donka National Hospital   (Guinea)

^c EpiScience   (United Kingdom)

^d University of Conakry   (Guinea)

^e CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^f INSERM   (France)

^g Macenta Prefect Hospital   (Guinea)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CHILD; COHORT ANALYSIS; DEPRESSION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EYE DISEASE; FEMALE; FOLLOW UP; GUINEA; HEADACHE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUSCULOSKELETAL PAIN; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SOCIAL STATUS; SURVIVOR; VIRUS TRANSMISSION; CLINICAL TRIAL; COMPLICATION; DISEASE OUTBREAKS; EYE DISEASES; HEMORRHAGIC FEVER, EBOLA; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PAIN; PATIENT CARE; PRESCHOOL CHILD; PROSPECTIVE STUDY; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EBOLAVIRUS; EYE DISEASES; FEMALE; GUINEA; HEADACHE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; MALE; MIDDLE AGED; PAIN; PATIENT CARE TEAM; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; VIRAL LOAD;

EID: 85018193000     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30516-3     Document Type: Article

References (30)

1. 1 Feldmann, H, Geisbert, TW, Ebola haemorrhagic fever. Lancet 377 (2011), 849–862.
2. 2 Baize, S, Pannetier, D, Oestereich, L, et al. Emergence of Zaire Ebola virus disease in Guinea—preliminary report. N Engl J Med 371 (2014), 1418–1425.
3. 3 WHO. Ebola data and statistics. Situation summary. http://apps.who.int/gho/data/view.ebola-sitrep.ebola-summary-20160511?lang=en, May 11, 2016 (accessed Dec 21, 2016).
4. 4 Kibadi, K, Mupapa, K, Kuvula, K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 179:suppl 1 (1999), S13–S14.
5. 5 Rowe, AK, Bertolli, J, Khan, AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 179:suppl 3 (1999), S28–S35.
6. 6 Bwaka, MA, Bonnet, MJ, Calain, P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 179:suppl 1 (1999), S1–S7.
7. 7 Rodriguez, LL, De Roo, a, Guimard, Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179:suppl (1999), S170–S176.
8. 8 Wendo, C, Caring for the survivors of Uganda's Ebola epidemic one year on. Lancet, 358, 2001, 1350.
9. 9 Bausch, DG, Sequelae after Ebola virus disease: even when it's over it's not over. Lancet Infect Dis 15 (2015), 865–866.
10. 10 Clark, DV, Kibuuka, H, Millard, M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 15 (2015), 905–912.
11. 11 Qureshi, AI, Chughtai, M, Loua, TO, et al. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis 61 (2015), 1035–1042.
12. 12 Mattia, JG, Vandy, MJ, Chang, JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 16 (2015), 331–338.
13. 13 Nanyonga, M, Saidu, J, Ramsay, A, Shindo, N, Bausch, DG, Sequelae of Ebola virus disease, Kenema District, Sierra Leone. Clin Infect Dis 62 (2016), 125–126.
14. 14 Scott, JT, Sesay, FR, Massaquoi, TA, Idriss, BR, Sahr, F, Semple, MG, Post-Ebola syndrome, Sierra Leone. Emerg Infect Dis 22 (2016), 641–646.
15. 15 Tiffany, A, Vetter, P, Mattia, J, et al. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis 62 (2016), 1360–1366.
16. 16 Vetter, P, Kaiser, L, Schibler, M, Ciglenecki, I, Bausch, DG, Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis 16 (2016), e82–e91.
17. 17 Fallah MP, Prevail III Research Team. A cohort study of survivors of Ebola virus infection in Liberia (PREVAIL III). Annual Conference on Retroviruses and Opportunistic Infections; Boston, MA; Feb 22–25, 2016. 74LB.
18. 18 Sissoko, D, Laouenan, C, Folkesson, E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med, 13, 2016, e1001967.
19. 19 van Griensven, J, Edwards, T, de Lamballerie, X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 374 (2016), 33–42.
20. 20 Barry, M, Touré, A, Traoré, FA, et al. Clinical predictors of mortality in patients with Ebola virus disease. Clin Infect Dis 60 (2015), 1821–1824.
21. 21 Deen, GF, Knust, B, Broutet, N, et al. Ebola RNA persistence in semen of Ebola virus disease survivors—preliminary report. N Engl J Med, 2015 published online Oct 14. DOI: 10.1056/NEJMoa1511410.
22. 22 Eggo, RM, Watson, CH, Camacho, A, Kucharski, AJ, Funk, S, Edmunds, WJ, Duration of ebola virus RNA persistence in semen of survivors: population-level estimates and projections. Euro Surveill, 20, 2015, 30083.
23. 23 Mate, SE, Kugelman, JR, Nyenswah, TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373 (2015), 2448–2454.
24. 24 Saliou, SM, Etard, J-F, Baize, S, et al. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. Clin Infect Dis 214 (2016), 1475–1476.
25. 25 Thorson, A, Formenty, P, Lofthouse, C, Broutet, N, Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open, 6, 2016, e008859.
26. 26 Vetter, P, Fischer, WA, Schibler, M, Jacobs, M, Bausch, DG, Kaiser, L, Ebola virus shedding and transmission: review of current evidence. J Infect Dis 214 (2016), S177–S184.
27. 27 Soka, MJ, Choi, MJ, Baller, A, et al. Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health 4 (2016), e736–e743.
28. 28 Diallo, B, Sissoko, D, Loman, NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63 (2016), 1353–1356.
29. 29 Henao-Restrepo, AM, Longini, IM, Egger, M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386 (2015), 857–866.
30. 30 Penttila, IA, Harris, RJ, Storm, P, Haynes, D, Worswick, DA, Marmion, BP, Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 91 (1998), 549–560.